Viking Therapeutics (VKTX) Misses Q2 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Viking Therapeutic (VKTX) PT Raised to $87 at Truist Securities
• B.Riley: 'We are aggressive buyers of Viking Therapeutics'
• Today’s Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals